Want to pull a list of companies using this tech? Use GTM.AI in your AI tool of choice
close
Homepage  >  Market Share  >  Other Operations Software  > 

Veeva QMS

Veeva QMS

By Veeva
  • #91 Software in Other Operations Software
  • Veeva QMS market share is 0.11% with more than 93 companies using this software
  • Datanyze helps you reach more than 473,132 contacts that are using Veeva QMS , including Thermo Fisher Scientific Roche CBRE

    Find Contacts

    Websites Added

    1

    arrow

    Current Websites

    93

    Websites Dropped

    N/A

    Market Share

    0.11%

    ABOUT VEEVA QMS

    Veeva QMS is a cloud-based quality management system designed to streamline and simplify quality processes for life sciences companies. It provides capabilities for managing deviations, audits, change control, and collaboration with external partners, while integrating with other Veeva Quality Cloud applications for unified quality assurance and control processes.

    Top industries using this technology

    Top competitors of Veeva QMS

    Top Competitors Websites Market Share Vendor
    14,376
    16.40%
    10,787
    12.31%
    6,682
    7.62%
    3,305
    3.77%
    3,293
    3.76%
    3,207
    3.66%
    2,715
    3.10%
    2,490
    2.84%
    2,184
    2.49%
    1,851
    2.11%
    See More

    Your Questions, Our Answers

    Get Free Access to Veeva QMS

    What is Veeva QMS and what is used for?

    Veeva QMS is a cloud-based quality management system designed to streamline and simplify quality processes for life sciences companies. It provides capabilities for managing deviations, audits, change control, and collaboration with external partners, while integrating with other Veeva Quality Cloud applications for unified quality assurance and control processes.

    Which software are similar or alternative to Veeva QMS

    GPS is one of the most well-known alternatives to Veeva QMS

    Who uses Veeva QMS?

    93 companies reportedly use Veeva QMS in their tech stacks, including Thermo Fisher Scientific, Roche, CBRE